BBOT
NASDAQ · Biotechnology
Bridgebio Oncology Therapeut
$4.66
+0.00 (+0.00%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Price Target
Analyst Price Target
+824.9% upside
Low Target
$22.76
Average Target
$43.10
High Target
$48.38
Current Price
$4.66
Current
$4.66
$4.66
Target
$43.10
$43.10
$22.76
$43.10 avg
$48.38
Scenario Analysis
Bear Case
$22.76
388.4%
Low target
Base Case
$43.10
+824.9%
Avg target
Bull Case
$48.38
+938.2%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$14.87
-68.7% from high
52-Week Low
$4.71
+-1.1% from low
Target vs 52W High
$43.10
+189.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.9% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.9% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -18.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -63.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |